Health Care · Pharmaceutical Preparations · Nasdaq · CIK 320017 · FYE Dec 31 · Prices AT CLOSE 2026-07-30 (USD) — end-of-day, never a live or intraday quote
Last $1.03Day −5.50%Mkt cap $10M1Y −59.3%Off 52W high −79.7%Vol (1Y) 119.9%
Daily closing price, split-adjusted to the current basis; 3y shown of 965 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest1.4% of sh out |
| Days to cover2.8d |
| 13F net flow (QoQ)+0.27% |
| Top-10 13F concentration83.3% |
| Next report (est.)2026-08-10 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$170,000 |
| Earnings (TTM)-$16.4M |
| ROE−74.7% |
| Net margin−9756.5% |
| ROIC−244.8% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−44.6% |
| 1Y−59.3% |
| 3Y−67.5% |
| Since incept. (ann.)−33.5% |
Total return through 2026-07-30 · series begins 2022-09-16. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)119.9% |
| Ann. volatility (3Y)89.3% |
| Sharpe (1Y)−0.27 |
| Sharpe (3Y)−0.02 |
| Max drawdown (1Y)−79.6% |
| Max drawdown (3Y)−79.6% |
| Beta (3Y vs SPY)0.43 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 271,815 | $1M | 3.01% | new |
| RENAISSANCE TECHNOLOGIES LLC | 131,715 | $659,892 | 1.46% | +6.5% |
| DELTEC ASSET MANAGEMENT LLC | 90,000 | $450,900 | 1.00% | new |
| Rangeley Capital, LLC | 75,000 | $375,750 | 0.83% | new |
| GEODE CAPITAL MANAGEMENT, LLC | 70,887 | $355,213 | 0.78% | +10.0% |
| CSS LLC/IL | 61,898 | $310,109 | 0.69% | new |
| BlackRock, Inc. | 54,857 | $274,834 | 0.61% | +0.0% |
| PenderFund Capital Management Ltd. | 47,500 | $237,975 | 0.53% | new |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-11 | −$0.50 | — | $0 | — |
| 2025-12-31 | 2026-03-12 | — | — | $100,000 | −90.0% |
| 2025-09-30 | 2025-11-06 | −$0.49 | — | $0 | — |
| 2025-06-30 | 2025-08-07 | −$0.54 | — | $70,000 | — |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-10 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
Reportable 100%
business segments · each slice's share of TAGGED segment revenue in the latest annual filing (XBRL, as filed). Untagged revenue is excluded from the denominator, so slices need not sum to consolidated sales.
